CDMO News
Nippon Shokubai Announces Major CDMO Expansion for Nucleic Acid APIs
Nippon Shokubai Co., Ltd. has announced plans to expand its manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) by tenfold. The upgrade will involve installing a large-scale production line capable of producing several kilograms per batch and is expected
25 June 2025